These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray. De Luca-Vinhas MC; Macedo CE; Brandão ML Pain; 2006 Mar; 121(1-2):94-104. PubMed ID: 16472918 [TBL] [Abstract][Full Text] [Related]
4. Role of neuroimmunomodulation in aging. De la Fuente M Neuroimmunomodulation; 2008; 15(4-6):213-23. PubMed ID: 19047799 [TBL] [Abstract][Full Text] [Related]
5. Contribution of spinal mu(1)-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar. Mizoguchi H; Ito K; Watanabe H; Watanabe C; Katsuyama S; Fujimura T; Sakurada T; Sakurada S Peptides; 2006 Nov; 27(11):2786-93. PubMed ID: 16919848 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. Galeotti N; Quattrone A; Vivoli E; Bartolini A; Ghelardini C Neuroscience; 2007 Oct; 149(2):409-20. PubMed ID: 17890015 [TBL] [Abstract][Full Text] [Related]
7. Neuroimmunomodulation in asthma: focus on the hypothalamic-pituitary-adrenal axis. Introduction. Priftis KN; Chrousos GP Neuroimmunomodulation; 2009; 16(5):263-4. PubMed ID: 19571586 [No Abstract] [Full Text] [Related]
8. Interaction of endogenous ligands mediating antinociception. Horvath G; Kekesi G Brain Res Rev; 2006 Aug; 52(1):69-92. PubMed ID: 16488019 [TBL] [Abstract][Full Text] [Related]
9. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism. Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080 [TBL] [Abstract][Full Text] [Related]
10. Involvement of GABAergic modulation of antinociception induced by morphine microinjected into the ventrolateral orbital cortex. Qu CL; Tang JS; Jia H Brain Res; 2006 Feb; 1073-1074():281-9. PubMed ID: 16448630 [TBL] [Abstract][Full Text] [Related]
15. Melatonin and tryptophan as therapeutic agents against the impairment of the sleep-wake cycle and immunosenescence due to aging in Streptopelia risoria. Paredes SD; Barriga C; Rodríguez AB Neuro Endocrinol Lett; 2007 Dec; 28(6):757-60. PubMed ID: 18063930 [TBL] [Abstract][Full Text] [Related]
16. The mitochondrion as a primary site of action of regulatory agents involved in neuroimmunomodulation. Psarra AM; Solakidi S; Sekeris CE Ann N Y Acad Sci; 2006 Nov; 1088():12-22. PubMed ID: 17192553 [TBL] [Abstract][Full Text] [Related]
17. Excitement over the chemistry of immune-nervous system relationships. Konsman JP Brain Behav Immun; 2006 May; 20(3):231-2. PubMed ID: 16460909 [No Abstract] [Full Text] [Related]
18. 'The emergence of neurotransmitters as immune modulators': letter to Rafael Franco and colleagues. Straub RH; Jessop DS Trends Immunol; 2008 Jul; 29(7):303; author reply 304-5. PubMed ID: 18524681 [No Abstract] [Full Text] [Related]
19. Ultra violet-induced localized inflammatory hyperalgesia in awake rats and the role of sensory and sympathetic innervation of the skin. Saadé NE; Farhat O; Rahal O; Safieh-Garabedian B; Le Bars D; Jabbur SJ Brain Behav Immun; 2008 Feb; 22(2):245-56. PubMed ID: 17884331 [TBL] [Abstract][Full Text] [Related]
20. Brain's firewall: blood-brain barrier actively regulates neuroimmune information flow. Quan N Brain Behav Immun; 2006 Sep; 20(5):447-8. PubMed ID: 16621441 [No Abstract] [Full Text] [Related] [Next] [New Search]